高通量基因测序技术在淋巴瘤中的应用进展

doi:10.6040/j.issn.1671-7554.0.2019.428

摘要/Abstract

摘要： 近年来,基于全基因组的高通量测序技术发展迅速,由于其速度快、准确率高、成本低等优点,目前已广泛应用在临床医学的各个领域,为亚型众多、治疗复杂的淋巴瘤研究带来了革命性变化,为筛选淋巴瘤的特异性诊断标志、研究疾病的发病机制、寻找预后指标及促进新药研发起到了极大的推动作用。

关键词: 淋巴瘤, 高通量测序, 基因组测序

Abstract: High-throughput sequencing technology based on whole-genome sequences has developed rapidly in recent years. Thanks to its high speed, high accuracy and low cost, it has been widely used in various fields of clinical medicine. It has also brought revolutionary changes for the diagnosis and treatment of numerous subtypes of lymphomas. The high-throughput sequencing has greatly promoted the development of lymphoma research, including screening specific diagnostic markers, exploring the pathogenesis of the diseases, finding prognostic indicators and promoting new drug development.

Key words: Lymphoma, High-throughput sequencing, Gene sequencing

中图分类号:

R733.4

王欣. 高通量基因测序技术在淋巴瘤中的应用进展[J]. 山东大学学报 (医学版), 2019, 57(7): 50-54.

WANG Xin. Development of gene sequencing in the diagnosis and treatment of lymphoma[J]. Journal of Shandong University (Health Sciences), 2019, 57(7): 50-54.

参考文献

[1] Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors [J]. Proc Natl Acad Sci USA, 1977, 74(12): 5463-5467.
[2] Maxam AM, Gilbert W. A new method for sequencing DNA [J]. Proc Nati Acad Sci, 1977, 74(2): 560-564.
[3] Mardis ER. Next-generation DNA sequencing methods [J]. Annu Rev Genomics Hum Genet, 2008, 9(1): 387-402.
[4] Schuster SC. Next-generation sequencing transforms todays biology [J]. Nat Methods, 2008, 5(1): 16-18.
[5] Sultan M, Schulz MH, Richard H, et al. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome [J]. Science, 2008, 321(5891): 956-960.
[6] Sabattini E, Bacci F, Sagramoso C, et al. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview [J]. Pathologica, 2010, 102(3): 83-87.
[7] Aoki R, Karube K, Sugita Y, et al. Distribution of malignant lymphoma in Japan: Analysis of 2260 cases, 2001-2006 [J]. Pathol Int, 2008, 58(3): 174-182.
[8] Taylor J, Xiao W, Abdel-Wahab O.Diagnosis and classification of hematologic malignancies on the basis of genetics [J]. Blood, 2017, 130(4): 410-423.
[9] Dobashi A. Molecular pathogenesis of diffuse Large B-cell lymphoma [J]. J Clin Exp Hematop, 2016, 56(2): 71-78.
[10] Gunawardana J, Chan FC, Telenius A, et al. Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma [J]. Nature Genetics, 2014, 46(4): 329-335.
[11] Reddy A, Zhang J, Davis NS, et al. Genetic and functional drivers of diffuse large b cell lymphoma [J]. Cell, 2017, 171(2): 481-494.
[12] Zhang J, Grubor V, Love CL,et al. Genetic heterogeneity of diffuse large B-cell lymphoma[J]. Proc Natl Acad Sci USA, 2013, 110(4): 1398-1403.
[13] Mareschal S, Dubois S, Viailly PJ, et al. Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma [J]. Genes Chromosomes Cancer, 2016, 55(3): 251-267.
[14] Novak AJ, Asmann YW, Maurer MJ, et al. Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma [J]. Blood Cancer Journal, 2015, 5(8): e346.
[15] Cornish AJ, Hoang PH, Dobbins SE, et al. Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C [J]. Blood Advances, 2019, 3(1): 21-32.
[16] Kridel R, Meissner B, Rogic S, et al. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma [J]. Blood, 2012, 119(9): 1963-1971.
[17] Bea S, Valdes-Mas R, Navarro A, et al. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma [J]. Proc Natl Acad Sci USA, 2013, 110(45): 18250-18255.
[18] Chiron D, Di Liberto M, Martin P, et al. Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma [J]. Cancer Discovery, 2014, 4(9): 1022-1035.
[19] Yang QP, Zhang WY, Yu JB, et al. Subtype distribution of lymphomas in Southwest China: Analysis of 6, 382 cases using WHO classification in a single institution [J]. Diagn Pathol, 2011, 6(1): 77.
[20] Xiong J, Zhao WL. Advances in multiple omics of natural-killer/T cell lymphoma [J]. J Hematol Oncol, 2018, 11: 134. doi:10.1186/s13045-018-0678-1.
[21] Jiang L, Gu ZH, Yan ZX, et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma [J]. Nat Genet, 2015, 47(9): 1061-1066.
[22] Palser AL, Grayson NE, White RE, et al. Genome diversity of epstein-barr virus from multiple tumor types and normal infection [J]. J Virol, 2015, 89(10): 5222-5237.
[23] Peng RJ, Han BW, Cai QQ, et al. Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma [J]. Leukemia, 2018. doi:10.1038/s41375-018-0324-5.
[24] Lau CC, Sun T, Ching AK, et al. Viral-human chimeric transcript predisposes risk to liver cancer development and progression [J]. Cancer Cell, 2014, 25(3): 335-349.
[25] Check Hayden E. Genome sequencing: the third generation [J]. Nature, 2009, 457(7231): 768-769.

相关文章 15

[1]	吴思雨,沈业隆,王锡明. 影像组学预测原发性中枢神经系统淋巴瘤的Ki-67标记指数[J]. 山东大学学报 (医学版), 2024, 62(11): 67-72.
[2]	杜圣红,李晓梅,陈晨,王玲. 鼻型弥漫大B细胞淋巴瘤合并肺腺癌1例并文献复习[J]. 山东大学学报 (医学版), 2023, 61(8): 111-115.
[3]	管伟,白云峰,杜胜杰,王月兰,李希明. 基于RNA高通量测序研究右美托咪定对人神经母细胞瘤细胞基因表达的影响[J]. 山东大学学报 (医学版), 2023, 61(7): 27-33.
[4]	谢晓丽, 邱雨, 王丽娟. 干扰素-γ通过PI3K/Akt/mTOR通路上调程序性死亡受体-配体1促进非霍奇金淋巴瘤细胞增殖[J]. 山东大学学报 (医学版), 2023, 61(5): 11-19.
[5]	王珊,焦伯延,冯强,段延华,温红玲. 2021年济宁市柯萨奇病毒A16型流行特点及全基因组特征[J]. 山东大学学报 (医学版), 2023, 61(5): 90-95.
[6]	孙晨曦, 王永静, 李爱, 宋宁霞, 陈慧娴, 冯晓丽, 邓玉鹏, 王涓冬, 郑成云. 1例罕见成年XLP-1病例报道[J]. 山东大学学报 (医学版), 2022, 60(3): 117-120.
[7]	李燕,陈萍,赵红玉,杨文采,周佩瑶,李大启. 奥布替尼联合PD-1抑制剂和来那度胺治疗继发性中枢神经系统淋巴瘤1例[J]. 山东大学学报 (医学版), 2022, 60(10): 120-124.
[8]	卢佳配,邢丽娜,滑欢,刘璇,牛志云,王颖,温树鹏,王福旭,张学军. 人类白细胞抗原亲缘半相合造血干细胞移植治疗T淋巴母细胞淋巴瘤2例报告及文献复习[J]. 山东大学学报 (医学版), 2020, 58(4): 121-129.
[9]	吴德沛,陈晓晨. 淋巴瘤免疫治疗的现状及展望[J]. 山东大学学报 (医学版), 2019, 57(7): 13-20.
[10]	周道斌,张炎. 原发性中枢神经系统淋巴瘤诊治现状及进展[J]. 山东大学学报 (医学版), 2019, 57(7): 31-39.
[11]	吕高超,蒋胜华,山凤莲,姜鲁宁. 以乳糜胸和纵隔占位为表现的淋巴瘤患者曲折诊治1例[J]. 山东大学学报 (医学版), 2019, 57(7): 117-121.
[12]	胡丽萍,王乐,金亮,刘燕霞,崔东清,曹丽丽. SYNE1基因复合杂合突变导致常染色体隐性小脑共济失调1型病例报告并文献复习[J]. 山东大学学报 (医学版), 2019, 57(11): 78-82.
[13]	王海涛. 去势抵抗性前列腺癌精准治疗的研究进展[J]. 山东大学学报 (医学版), 2019, 57(1): 30-35.
[14]	谢炜星,丁金勇,陈伟健,任东成,晋大祥. 腰椎管狭窄症合并左骶髂关节弥漫性大B细胞淋巴瘤1例[J]. 山东大学学报 (医学版), 2018, 56(9): 93-96.
[15]	宋立锦,顾湘,李理想,李铭,左秀丽,李延青. 具核梭杆菌灌胃对大鼠肠道菌群的影响[J]. 山东大学学报 (医学版), 2018, 56(7): 7-14.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed